Multidisciplinary Diagnosis and Treatment of Extranodal Nasal Type NK/T Cell Lymphoma with Oral Mucosal Ulcer as the First Manifestation: A Case Report

doi:10.13701/j.cnki.kqyxyj.2024.03.017

Abstract

Abstract: Extranodal NK/T cell lymphoma, nasal type (ENKTL), is a rare and unique non-Hodgkin's lymphoma that primarily affects the middle face and originates from T cells or NK cells. It is uncommon for cases to present with an oral ulcer as the initial symptom, which can lead to confusion with other diseases and pose challenges for diagnosis. This paper presents a case study on the diagnosis and treatment of Extranodal NK/T-cell lymphoma, nasal type (ENKTL) with initial symptoms of buccal mucosa and gingival ulcer. It analyzes the clinicopathological characteristics, diagnosis, differential diagnosis, and treatment of the disease to offer guidance for clinical management of similar cases.

Key words: extranodal NK/T cell lymphoma, oral ulcer, multidisciplinary diagnosis and treatment

WANG Feng, CHEN Xuya, ZHOU Gang, ZHANG Jing. Multidisciplinary Diagnosis and Treatment of Extranodal Nasal Type NK/T Cell Lymphoma with Oral Mucosal Ulcer as the First Manifestation: A Case Report[J]. Journal of Oral Science Research, 2024, 40(3): 275-278.

References

[1] Tse E, Kwong YL. The diagnosis and management of NK/T-cell lymphomas [J]. J Hematol Oncol, 2017, 10(1):85.
[2] Wu X, Li P, Zhao J, et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type [J]. Clin Oncol (R Coll Radiol), 2008, 20(8):619-625.
[3] Haverkos BM, Pan Z, Gru AA, et al. Extranodal NK/T cell lymphoma, nasal type (ENKTL-NT): An update on epidemiology, clinical presentation, and natural history in north American and European cases [J]. Curr Hematol Malig Rep, 2016, 11(6): 514-527.
[4] Harabuchi Y, Takahara M, Kishibe K, et al. Extranodal natural killer/T-cell lymphoma, nasal type: Basic science and clinical progress [J]. Front Pediatr, 2019, 7:141.
[5] 王丹丹,杨宏宇,王宇帆,等.伴面部肿胀结外鼻型NK/T细胞淋巴瘤1例报告及文献复习[J].中国口腔颌面外科杂志,2017,15(4):382-384.
[6] 沙秀娟,江姗,杨冬叶,等.1例鼻腔NK/T细胞淋巴瘤伴发腭部缺损患者行腭护板修复的个案护理[J].中国口腔医学继续教育杂志,2022,25(6):397-401.
[7] Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms [J]. Blood, 2016, 127(20): 2375-2390.
[8] 穆新月,刘树泰,孙继军,等.以口腔溃疡为首发症状的鼻型-结外自然杀伤/T细胞淋巴瘤1例[J].华西口腔医学杂志,2022,40(3):355-359.
[9] Nagato T, Takahara M, Harabuchi Y. Ulcerated lesions of the midline gingiva and soft palate [J]. Am J Med Sci, 2020, 360(1): 77.
[10] Niwa H, Mukai K, Kimura I, et al. A case of extranodal NK/T-cell lymphoma, nasal type, diagnosed by scraping cytology of the maxillary gingiva [J]. Diagn Cytopathol, 2024, 52(2):E39-E43.
[11] Al-Hakeem DA, Fedele S, Carlos R, et al. Extranodal NK/T-cell lymphoma, nasal type [J]. Oral Oncology, 2007, 43(1): 4-14.
[12] Horwitz SM, Ansell SM, Ai WZ, et al. NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018 [J]. J Natl Compr Canc Netw, 2018, 16(2):123-135.
[13] Sánchez-Romero C, Bologna-Molina R, Paes de Almeida O, et al. Extranodal NK/T cell lymphoma, nasal type: An updated overview [J]. Crit Rev Oncol Hematol, 2021, 159:103237.
[14] Meng W, Zhou Y, Zhang H, et al. Nasal-type NK/T-cell lymphoma with palatal ulcer as the earliest clinical manifestation: a case report with literature review[J]. Pathol Oncol Res, 2010, 16(1):133-137.
[15] Tian C, Wang Y, Zhu L, et al. Primary bone natural killer/T cell lymphoma, nasal type without EBV infection: a case report [J]. Int J Clin Exp Pathol, 2015, 8(11): 14836-14839.
[16] Hue SS, Oon ML, Wang S, et al. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach [J]. Pathology, 2020, 52(1): 111-27.
[17] Syrykh C, Péricart S, Lamaison C, et al. Epstein-barr virus-associated T- and NK-cell lymphoproliferative diseases: A review of clinical and pathological features [J]. Cancers (Basel), 2021, 13(13):3315.
[18] He X, Gao Y, Li Z, et al. Review on natural killer/T-cell lymphoma [J]. Hematol Oncol, 2023, 41(2): 221-229.
[19] Tse E, Zhao WL, Xiong J, et al. How we treat NK/T-cell lymphomas[J]. J Hematol Oncol, 2022, 15(1): 74.
[20] Wang H, Fu BB, Gale RP, et al. NK-/T-cell lymphomas [J]. Leukemia, 2021, 35(9): 2460-2468.